Older people who received transfusions of young blood plasma have shown improvements in biomarkers related to cancer, Alzheimer’s disease and heart disease, New Scientist has learned.“I don’t want to say the word panacea, but here’s something about teenagers,” Jesse Karmazin, founder of startup Ambrosia, told New Scientist. “Whatever is in young blood is causing changes that appear to make the ageing process reverse.”Since August 2016, Karmazin’s company has been transfusing people aged 35 and older wit

Source: Human tests suggest young blood cuts cancer and Alzheimer’s risk | New Scientist